Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Weber Chuang

Urology Arlington, TX Medical Doctor

NPI 1669468633 CMS profile 301956

5005 S Cooper St Ste 250, Arlington, TX 76017

Open in the dashboard

General payments

$3,263

179 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Weber Chuang of Arlington, TX is reported in the CMS Open Payments database as having received $3,263 across 179 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 54th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $353 10
2024 General $306 15
2023 General $375 17
2022 General $745 39
2021 General $736 56
2020 General $277 15
2019 General $471 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Weber Chuang
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Weber Chuang were reported at $353. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Weber Chuang Urology median Middle half National median
2019 $471 $480 $147–$1,201 $163
2020 $277 $246 $87–$645 $114
2021 $736 $358 $111–$1,000 $132
2022 $745 $476 $143–$1,263 $149
2023 $375 $560 $168–$1,461 $160
2024 $306 $563 $170–$1,464 $164
2025 $353 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $636 45 payments
  2. Dendreon Pharmaceuticals LLC $308 17 payments
  3. Astellas Pharma US Inc $237 14 payments
  4. Endo Pharmaceuticals Inc. $222 19 payments
  5. Boston Scientific Corporation $216 3 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $189 10 payments
  7. Sumitomo Pharma America, Inc. $153 8 payments
  8. Blue Earth Diagnostics Limited $153 7 payments
  9. Myovant Sciences Inc. $149 8 payments
  10. Axonics Modulation Technologies, Inc. $142 2 payments
  11. Other $859 46 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,263 179 payments
Products named General payments · program years 2019–2025
  1. PROVENGE $308 17 payments
  2. LUPRON DEPOT $304 26 payments
  3. ORGOVYX $302 16 payments
  4. BOTOX $245 13 payments
  5. MYRBETRIQ $237 14 payments
  6. AVEED $222 19 payments
  7. XIAFLEX $222 19 payments
  8. EDEX $200 18 payments
  9. Nubeqa $189 10 payments
  10. Xofigo $143 8 payments
  11. Other $1,672 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

672

Median for Urology: 1,053

Drug cost

$41,233

Median for Urology: $101,464

Branded share of claims

13.4%

Median for Urology: 27.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gemtesa Vibegron Brand 54 $28,881
Tamsulosin Hcl Generic 279 $4,428
Testosterone Generic 39 $3,627
Testosterone Cypionate Generic 55 $1,849
Finasteride Generic 116 $1,283
Naproxen Generic 51 $520
Cephalexin Generic 19 $331
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 36 $200
Anastrozole Generic 11 $70
Levofloxacin Generic 12 $45

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$232,512

Medicare's payments for the services billed

Medicare patients

321

Average age 72

Services billed

3,792

28 women, 293 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Diabetes 33%
Ischemic heart disease 28%
Cancer 26%
Chronic kidney disease 24%
Atrial fibrillation 18%
Depression 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $75
$75 — —
ORGOVYX
  • Sumitomo Pharma America, Inc. $68
$68 — —
Nubeqa
  • Bayer HealthCare Pharmaceuticals Inc. $8
$8 — —
Xofigo
  • Bayer HealthCare Pharmaceuticals Inc. $8
$8 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

179 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record